VivoSim Labs (VIVS) Other Operating Expenses (2010 - 2024)

VivoSim Labs (VIVS) posted quarterly Other Operating Expenses of $2000.0 for Q4 2024, up 100.0% quarter-over-quarter from $1000.0 in Q3 2024.

VivoSim Labs (VIVS) Other Operating Expenses (2010 - 2024) Analysis & Trends

VivoSim Labs' Other Operating Expenses history runs 12 years deep, the most recent figure standing at $2000.0 for Q4 2024.

In Q4 2024, Other Operating Expenses changed N/A year-over-year to $2000.0; the TTM figure through Sep 2025 stood at $2000.0 (down 33.33% YoY), while the FY2025 annual figure was $10.0 million, changed N/A from the prior year.
Other Operating Expenses for Q4 2024 stood at $2000.0, up from $1000.0 in the prior quarter.
The five-year high for Other Operating Expenses was $6000.0 in Q2 2020, with the low at -$20000.0 in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-
10	VivoSim Labs	1.49 Mn	1.49 Mn	-

Download Data